• DNDi logo
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • COVID-19
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Global Headquarters
      • DNDi DRC
      • DNDi East Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
DNDi logo
  • DNDi logo
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • COVID-19
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Global Headquarters
      • DNDi DRC
      • DNDi East Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > News

Inaugural DNDi training for health & science journalists in Kampala

Home > News

Inaugural DNDi training for health & science journalists in Kampala

16 Oct 2018
Share on twitter
Share on facebook
Share on linkedin
Share on email
Share on print

A female participant talking in a microphone

In early October, 18 journalists from 11 African countries converged in Kampala, Uganda for DNDi’s first-ever training on health and science journalism. The three-day training was conducted on the sidelines of DNDi’s 11th Partners’ Meeting on 4 October 2018.

The objective of the health and science journalism workshop was to help reporters and editors better understand neglected diseases prevalent in the region and grasp the science behind efforts to develop new drugs for these diseases.

Mr Otula Owuor, a veteran Kenyan science journalist and trainer with the World Federation of Science Journalists, facilitated the training, which alternated presentations with interactive sessions. The journalists learned about neglected diseases directly from DNDi experts, including onchocerciasis (river blindness), mycetoma, human African trypanosomiasis (sleeping sickness), and leishmaniasis, and neglected patient populations such as children living with HIV. Dr Nathalie Strub-Wourgaft, Director of Neglected Tropical Diseases at DNDi, helped to “demystify” the clinical trials process with an in-depth talk on the ins and outs of drug development.

The journalists visited the Joint Clinical Research Centre in Lubowa, a clinical trial site for DNDi’s LIVING study, underway in Kenya and Uganda to demonstrate the effectiveness, safety, and acceptability of child-adapted HIV therapy, the so-called “2-in-1” pellets containing lopinavir and ritonavir (LPV/r), which are designed for infants and young children. The visit helped to improve the journalists’ understanding of what takes place during a clinical trial and gave them the opportunity to ask questions of Ugandan clinical trial experts.

Equipped with new skills and understanding, the journalists are already developing stories about neglected diseases and patients in their countries, and about related research and development activities.

A selection of articles published by participants of the workshop:

  • Al Jazeera Africa [27 March 2019] طبيبة كينية تعالج الناس بالصحافة “A Kenyan doctor treats people in the press”
  • New Business Ethiopia [9 February 2019] “Ethiopia makes progress against neglected tropical diseases”
  • The East African [1 November 2018] “New treatments offer hope for tropical diseases in Africa”
  • Habari RDC [24 October 2018] “Un nouveau medicament pour soigner la maladie du sommeil”
  • Politico DRC [14 October 2018] “Maladies tropicales négligées:les experts signalent des progrès dans l’éradication de la Trypanosomiase en RDC”
  • The Citizen [11 October 2018] “Children’s HIV drug formula developed”
  • Ghana Web [11 October 2018] “More resources needed to fight against neglected tropical diseases – Health experts”
  • Ghana Web [11 October 2018] “Pediatric HIV victims get attention”
  • Daily Monitor [10 October 2018] “HIV-positive children to take soluble ARVs”
  • The Star Tribune [8 October 2018] “Health organization celebrates 15 years fighting neglected diseases globally”
  • New Business Ethiopia [3 October 2018] “New clinical trials for neglected diseases in eastern Africa in progress”
  • Daily Nation [3 October 2018] “Children to get HIV drugs in powder form”
  • The Standard [3 October 2018] “Ray of hope for children with HIV and Aids”
Strengthening Capacities Paediatric HIV Africa Uganda

Read, watch, share

Loading...
Statements
24 May 2022

DNDi interventions at the 75th World Health Assembly

Hand holding pill
Publications
23 May 2022

Best science for all

Laboratory activities
Press releases
18 May 2022

Consortium formed to discover antivirals for COVID-19 receives NIH funding to develop globally accessible treatments for pandemics

Researcher working in a laboratory setting
News
18 May 2022

Health Journalists from Africa receive grants to report on COVID-19

After a serious outbreak of dengue fever in the Chinatown area of Bangkok in which a man died, the Bangkok Metropolitan Administration came in to fumigate the area and advise locals on possible breeding ground of mosquitos.
Press releases
29 Apr 2022

Ministry of Health, Malaysia and Drugs for Neglected Diseases initiative combine forces to lead the battle against dengue

News
22 Apr 2022

DNDi calls for nominations for a new Audit Committee Member

Microscope and computer
Press releases
20 Apr 2022

DNDi and BenevolentAI collaborate to accelerate life-saving drug discovery research in dengue

Woman looking up
Stories
13 Apr 2022

Early diagnosis and treatment can save millions of lives

VIEW ALL

Help neglected patients

To date, we have delivered nine new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
DNDi logo
Facebook-f
Twitter
Instagram
Linkedin-in
Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License